Delivery Order SPE2DB20D3103-SPE2DB22FN9X7
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $4,421.16 for the pharmaceutical product MULTIHANCE 529 MG/ML VIAL 10ML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the...
- This federal contract award is for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,298.40 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is also a significant federal contractor. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen...
- This is a federal contract award to Amerisourcebergen Drug Corp, a division of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $1,208.48, is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a pharmaceutical product. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts, including a significant Indefinite Delivery Contract...
- This federal contract award, with an ID of SPE2DB20D3103|SPE2DB22FN9D3, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MULTIHANCE 529 MG/ML VIAL 20ML, a medical product, with an ultimate completion date of June 15, 2022 and a ceiling value of $5,989.50. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (20 ml units) under a firm fixed price contract with a ceiling value of $9,105.30. The award was made on November 20, 2025, with an ultimate completion date of November 21, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Multihance 529 mg/ml vials (10 ml) valued at $2,203.22 under a firm fixed price contract type. The award was made on October 23, 2025, with an ultimate completion date of October 24, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this order at its corporate office...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $2,015.36 from the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of OMNIPAQUE 240 MG/ML VIAL 10ML, a pharmaceutical product, with a period of performance ending on January 27, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of OMNIPAQUE 350 MG/ML PLUSPAK 500ML medical supplies. The $6,940.82 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The contract has an ultimate completion date of March 7, 2024 and was awarded on March 6, 2024. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award, valued at $11,502.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a delivery order under the company's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies, including...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a Delivery Order contract worth $87,944.19 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $87,944.19 and an ultimate completion date of May 1, 2023. The contract is not designated with a set-aside. This Delivery Order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB22FN9X7Delivery Order
This contract award, valued at $3,091.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MULTIHANCE 529 MG/ML VIAL 10ML. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of June 23, 2022. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs globally. This contract award falls under the scope of that larger IDC.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 6/22/22 |